Tounjian Advisory Partners’s Medpace MEDP Stock Holding History

Tounjian Advisory Partners’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06K	Buy	+2	New	+$923	﹤0.01%	656

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Tounjian Advisory Partners's MEDP Position: Q2 2026 in Review

Tounjian Advisory Partners opened a new position in Medpace (MEDP) in Q2 2026: 2 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #656 among its holdings.

380 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Tounjian Advisory Partners held 2 shares of Medpace worth $1.06K as of Q2 2026.
Medpace was a new Tounjian Advisory Partners position in Q2 2026.
Medpace made up ﹤0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #656 holding.
380 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.